[Statin-induced Parkinson's-syndrome. Reader's letter on the article by J. Finsterer in "Der Nervenarzt" (2003) 74:115-122].
Müller
Th
T
Neurologische Universitätsklinik im St. Josef-Hospital, Ruhr-Universität Bochum, Gudrunstrasse. 56, 44791 Bochum. thomas.mueller@ruhr-uni-bochum.de
D000924:Anticholesteremic Agents / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D008148:Lovastatin / Q000009:adverse effects*; D009135:Muscular Diseases / Q000139:chemically induced; D020734:Parkinsonian Disorders / Q000139:chemically induced*; D012206:Rhabdomyolysis / Q000139:chemically induced*
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008148:Lovastatin